Dr. Jane Allison Little, MD

Dr. Little practices at UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System.

Dr. Little's NPI, 1699873430, was assigned on September 20, 2006. Dr. Little graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 1985. Dr. Little holds North Carolina license 2019-01347.

Dr. Little's primary practice is UNC Hospitals, at 101 Manning Drive, Chapel Hill, NC 27514 in Orange County. The practice phone is (919) 966-4141.

Dr. Little's primary practice is UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System. The medical group on file is UNC Faculty Physicians. Dmand AI also links Dr. Little to 3 more group practices and clinics, 2 medical groups and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Little practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Little's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Little's licenses on file in 3 states: North Carolina, New York and Ohio.

CMS data shows 59 Medicare services from Dr. Little across 2 procedure codes in 2024, for 32 Medicare patients. Medicare paid $3,667 for them. Every service was in an office.

CMS counts 32 Medicare patients who saw Dr. Little in 2024. 56% of them have mood disorders, and 50% have anxiety. 59% are also on Medicaid. Their average risk score is 4.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Little's median patient age at 45, with 54% women.

In 2024, Dr. Little wrote 143 Medicare Part D claims for 41 patients. 57% of them were for generic drugs. CMS names the drug for 76 of them, across 4 drugs with 11 or more claims each, at $64,245 in total drug cost. In 2023, CMS named 16 claims across 1 drug.

Dr. Little accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 76 papers to Dr. Little, published from 2011 to 2025. 2019 was the busiest year, with 8. The most frequent topics are Anemia, Sickle Cell, Erythrocytes and Cell Adhesion. Dr. Little has published most often in Br J Haematol. Dr. Little's most frequent co-authors are Mark T. Gladwin, Victor R. Gordeuk, MD and Gregory James Kato, MD.

Dmand AI links Dr. Little to 7 clinical trials, 2 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Anemia, Sickle Cell, Anemia, Hemolytic, Congenital and Acidosis. University Hospitals Cleveland Medical Center sponsors the most, 2.

CMS Open Payments shows 15 general payments to Dr. Little from 9 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $79. It also lists 2 research payments totaling $1,086 from 2021 to 2023.

Dr. Little graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 1985.